Literature DB >> 9698069

Tissue remodelling in the adrenal gland.

G W Wolkersdörfer1, S R Bornstein.   

Abstract

Adaptation of the adrenal gland to the demands of the organism is regulated functionally and structurally. Three common hypotheses on zonation in the adrenal gland, the migrational, zonal, and transformation field theories, try independently to reconcile the findings on structure, proliferation, and cell death. The classical theories on zonation are revisited in the light of recent data on cell death and renewal. In accordance with data on cell death as immunoreactivity against FAS(CD 95), an apoptosis-inducing receptor, in situ end labelling of fragmented DNA, and ultrastructural analyses, programmed cell death (PCD) occurs throughout the whole organ. The angiotensin II receptor subtypes described in the adrenal allow an additional regulation of tissue homeostasis by proliferative and even by the antiproliferative effects of the angiotensin II type 2 receptor. Proto-oncogenes are involved in the regulation of cell cycle and PCD, and adrenocorticotropin asserts its tissue integrating and differentiating effects by regulating proto-oncogenes such as c-jun, c-fos, jun-B and c-myc. Polypeptides involved in proliferation and DNA repair, such as proliferating cell nuclear antigen and Ki-67, have been found within zones of expected cell senescence. The expression of the class II major histocompatibility complex on normal adrenocortical cells allows cell-to-cell communication with the immune system and may trigger the Fas/Fas-ligand system to permit tissue regression and decreasing activity in both systems. In summary, new data allow us to reappraise and to reconcile the classical theories. Apoptosis is a physiological process in the adrenal gland. There is a differential regulation of apoptosis in the different zones. An investigation of this process may elucidate the basic mechanisms of adrenal zonation.

Entities:  

Mesh:

Year:  1998        PMID: 9698069     DOI: 10.1016/s0006-2952(98)00067-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

Review 1.  Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit.

Authors:  Hitoshi Ishimoto; Robert B Jaffe
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

2.  Different Somatic Mutations in Multinodular Adrenals With Aldosterone-Producing Adenoma.

Authors:  Fabio Luiz Fernandes-Rosa; Isabelle Giscos-Douriez; Laurence Amar; Celso E Gomez-Sanchez; Tchao Meatchi; Sheerazed Boulkroun; Maria-Christina Zennaro
Journal:  Hypertension       Date:  2015-09-08       Impact factor: 10.190

3.  Alteration of subcapsular adrenocortical zonation in humans with aging: the progenitor zone predominates over the previously well-developed zona glomerulosa after 40 years of age.

Authors:  Motohiko Aiba; Mariko Fujibayashi
Journal:  J Histochem Cytochem       Date:  2011-03-16       Impact factor: 2.479

4.  Androgen receptor-mediated regulation of adrenocortical activity in the sand rat, Psammomys obesus.

Authors:  Abdelouafi Benmouloud; Zaina Amirat; Farida Khammar; Alexandre V Patchev; Jean M Exbrayat; Osborne F X Almeida
Journal:  J Comp Physiol B       Date:  2014-09-02       Impact factor: 2.200

Review 5.  Expression of the IGF and the aromatase/estrogen receptor systems in human adrenal tissues from early infancy to late puberty: implications for the development of adrenarche.

Authors:  Alicia Belgorosky; María Sonia Baquedano; Gabriela Guercio; Marco A Rivarola
Journal:  Rev Endocr Metab Disord       Date:  2009-03       Impact factor: 6.514

6.  Changes in morphology and function of adrenal cortex in mice fed a high-fat diet.

Authors:  M M Swierczynska; I Mateska; M Peitzsch; S R Bornstein; T Chavakis; G Eisenhofer; V Lamounier-Zepter; S Eaton
Journal:  Int J Obes (Lond)       Date:  2014-06-12       Impact factor: 5.095

Review 7.  Functional Zonation of the Adult Mammalian Adrenal Cortex.

Authors:  Gavin P Vinson
Journal:  Front Neurosci       Date:  2016-06-15       Impact factor: 4.677

8.  Preclinical and Early Clinical Profile of a Highly Selective and Potent Oral Inhibitor of Aldosterone Synthase (CYP11B2).

Authors:  Katrijn Bogman; Dietmar Schwab; Marie-Laure Delporte; Giuseppe Palermo; Kurt Amrein; Susanne Mohr; Maria Cristina De Vera Mudry; Morris J Brown; Philippe Ferber
Journal:  Hypertension       Date:  2016-11-21       Impact factor: 10.190

9.  Insulin and obesity transform hypothalamic-pituitary-adrenal axis stemness and function in a hyperactive state.

Authors:  Martin Werdermann; Ilona Berger; Laura D Scriba; Alice Santambrogio; Pia Schlinkert; Heike Brendel; Henning Morawietz; Andreas Schedl; Mirko Peitzsch; Aileen J F King; Cynthia L Andoniadou; Stefan R Bornstein; Charlotte Steenblock
Journal:  Mol Metab       Date:  2020-11-04       Impact factor: 7.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.